During the past decade, Qingdao Municipal Hospital conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 7 clinical trials were completed, i.e. on average, 19.4% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 6 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Qingdao Municipal Hospital" #1 sponsor was "Jiangsu Simcere Pharmaceutical Co., Ltd." with 3 trials, followed by "Second Affiliated Hospital, School of Medicine, Zhejiang University" with 3 trials sponsored, "Beijing Kawin Technology Share-Holding Co., Ltd." with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Capital Medical University" with 2 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Qingdao Municipal Hospital" #1 collaborator was "Qingdao Municipal Hospital" with 6 trials as a collaborator, "Fujian Medical University Union Hospital" with 4 trials as a collaborator, "Shandong Provincial Hospital" with 4 trials as a collaborator, "Beijing Chao Yang Hospital" with 3 trials as a collaborator and "China-Japan Friendship Hospital" with 3 trials as a collaborator. Other collaborators include 202 different institutions and companies that were collaborators in the rest 130 trials.

According to Clinical.Site data, the most researched conditions in "Qingdao Municipal Hospital" are "Community Acquired Pneumonia" (3 trials), "Stroke" (3 trials), "Acute Ischemic Stroke" (2 trials), "Airway Responsiveness" (2 trials) and "Alzheimer Disease" (2 trials). Many other conditions were trialed in "Qingdao Municipal Hospital" in a lesser frequency.

Most popular intervention types in "Qingdao Municipal Hospital" are "Drug" (38 trials), "Other" (4 trials), "Procedure" (4 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "placebo" (3 trials), "Cisplatin" (2 trials), "Compound Edaravone Injection" (2 trials) and "Edaravone Injection" (2 trials). Other intervention names were less common.

The vast majority of trials in "Qingdao Municipal Hospital" are 47 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Qingdao Municipal Hospital". undefined are not yet recruiting, 13 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 23 completed trials in Qingdao Municipal Hospital, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Qingdao Municipal Hospital, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 9 trials that are defined as “Not Applicable".

Qingdao Municipal Hospital has several departments that took part in Clinical trials: "The affiliated hospital of medicalcollege qingdao university" - 6 trials